| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/06/2005 | EP1519757A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 04/06/2005 | EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 04/06/2005 | EP1519748A1 Microparticle with cd28-specific monoclonal antibodies |
| 04/06/2005 | EP1519745A1 Method to enhance an immune response of nucleic acid vaccination |
| 04/06/2005 | EP1519744A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 04/06/2005 | EP1519737A2 Fibrin nanoparticles and uses thereof |
| 04/06/2005 | EP1519734A1 Ciclesonide-containing sterile aqueous suspension |
| 04/06/2005 | EP1519731A1 Combination of azelastine and steroids |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1519718A1 At least partially degradable films containing an active ingredient and method for the production thereof |
| 04/06/2005 | EP1519717A1 Controlled release composition |
| 04/06/2005 | EP1519716A1 Extended-release tablets comprising divalproex sodium |
| 04/06/2005 | EP1519715A2 Nanoparticulate fibrate formulations |
| 04/06/2005 | EP1519714A1 Method and apparatus for producing liposomes |
| 04/06/2005 | EP1519713A2 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 04/06/2005 | EP1519712A1 Combination therapy and means for carrying out said therapy |
| 04/06/2005 | EP1519711A1 Controlled-release pharmaceutical formulations |
| 04/06/2005 | EP1519707A1 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous lipids |
| 04/06/2005 | EP1519704A2 Spherical pellet containing a water-soluble active ingredient |
| 04/06/2005 | EP1485818A4 Treatment protocol generation for diseases related to angiogenesis |
| 04/06/2005 | EP1359903B1 Method and device for producing thin wafers from a film of active ingredients |
| 04/06/2005 | EP1321140B1 Ibuprofen solutions for capsule-filling and capsule preparations |
| 04/06/2005 | EP1280499A4 Polymeric delivery and release systems for oral care actives |
| 04/06/2005 | EP1248652B1 Stable aqueous deoxyfructosazine solution |
| 04/06/2005 | EP1239840B1 Antiviral medication |
| 04/06/2005 | EP1231918B1 Novel composition based on a thiazolidinedione and metformin and use |
| 04/06/2005 | EP1028733B1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations |
| 04/06/2005 | EP1006964B1 Intrauterine chemical necrosing compositions and apparatus |
| 04/06/2005 | EP0988029B1 Device and methods for wound treatment |
| 04/06/2005 | EP0981373B1 Biofunctional polymers prepared in supercritical fluid |
| 04/06/2005 | EP0958813B1 Sustained-release preparation utilizing thermal change and process for the production thereof |
| 04/06/2005 | EP0847757B1 Medicine comprising hgf gene |
| 04/06/2005 | EP0802790B1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 04/06/2005 | EP0801561B1 Composition and methods for transdermal delivery of acid-labile drugs |
| 04/06/2005 | EP0663013B1 Method for delivering nucleic acids into cells |
| 04/06/2005 | CN2689944Y Chitosan medical film wound plaster |
| 04/06/2005 | CN1604794A Eye drops |
| 04/06/2005 | CN1604793A Methods of treatment and formulations of cephalosporin |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604788A High-concentration protein formulations and method of manufacture |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1604784A Heparin-containing ophthalmic agent |
| 04/06/2005 | CN1604782A Stabilized brivudine topical formulations |
| 04/06/2005 | CN1604781A Use of desoxypeganine for treating clinical depression |
| 04/06/2005 | CN1604777A Method of treatment |
| 04/06/2005 | CN1604773A Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1604771A Coated tablets and process for producing the same |
| 04/06/2005 | CN1604770A Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 04/06/2005 | CN1603263A Use of glass compositions for achieving an antioxidative effect |
| 04/06/2005 | CN1602961A Ointment auxiliary agent and preparation thereof |
| 04/06/2005 | CN1602956A Deactivated BCG for treating disease |
| 04/06/2005 | CN1602951A Nasally administered formulation of osteogenic growth peptide |
| 04/06/2005 | CN1602949A Compound capsule for treating apoplexy involving the meridians of wind phlegm stasis blockage syndrome type and preparation process thereof |
| 04/06/2005 | CN1602948A Gingko leaf dispersible tablet and its preparing process |
| 04/06/2005 | CN1602946A Buccal tablets for treating acute and chronic pharyngitis and stomatitis and its preparation process |
| 04/06/2005 | CN1602945A Rhinitis treating soft medicinal capsule and preparation process thereof |
| 04/06/2005 | CN1602944A Compound plaster of dahurian angelica root and its preparation method |
| 04/06/2005 | CN1602941A Chinese medicinal formulation for treating pelvic inflammation with improved bioavailability and drug effect and preparation process thereof |
| 04/06/2005 | CN1602940A Orally quick releasing tablet of compound red sage root, its medical uses and preparation process |
| 04/06/2005 | CN1602939A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 04/06/2005 | CN1602938A Leukemia treating pills |
| 04/06/2005 | CN1602937A Beautifying and climacteric syndrome treating composition, its preparing process and usage |
| 04/06/2005 | CN1602934A Chinese medicinal powder for treating toothache |
| 04/06/2005 | CN1602933A Capsule for treating tuberculosis and its preparing process |
| 04/06/2005 | CN1602929A Traditional Chinese medicine composition for treating nephritis and uraemia |
| 04/06/2005 | CN1602927A Wind expelling, toxin removing bone reaching powder |
| 04/06/2005 | CN1602926A Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases |
| 04/06/2005 | CN1602925A Process for preparing Chinese medicinal mini powder |
| 04/06/2005 | CN1602924A Chinese medicinal composition for treating bronchitis and preparing method thereof |
| 04/06/2005 | CN1602923A Chinese traditional medicine for treating kidney disease and nephrotic syndrome and its preparation method |
| 04/06/2005 | CN1602921A Medicine for treating diabetes and its preparing process |
| 04/06/2005 | CN1602920A Gingko leaf extracts with superior quality and its manufacturing technique |
| 04/06/2005 | CN1602919A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 04/06/2005 | CN1602918A Astragalus root and Breviscapine containing Chinese medicinal formulation and its preparation and application |
| 04/06/2005 | CN1602917A 'Shengmai' formulation and its preparation process |
| 04/06/2005 | CN1602916A Medicine for treating piles and its preparing process |
| 04/06/2005 | CN1602915A Stomach motility promoting medicine for treating stomach and intestine function failure and its preparation |
| 04/06/2005 | CN1602914A Tumor eliminating powder |
| 04/06/2005 | CN1602913A Pelvic inflammation treating traditional Chinese medicinal preparation |
| 04/06/2005 | CN1602912A Ointment for treating closed fracture |
| 04/06/2005 | CN1602909A Externally applied medicine for treating hyperosteogeny and preparation method thereof |
| 04/06/2005 | CN1602908A Scald treating ointment |
| 04/06/2005 | CN1602907A Medicine for treating chronic bronchitis and asthma |
| 04/06/2005 | CN1602906A Medicine for treating rhinitis and its preparing process |
| 04/06/2005 | CN1602905A Externally applied medicine for treating hyperosteogeny and intervertebral disc protrusion and its preparation method |
| 04/06/2005 | CN1602903A Live-soothing fat-reducing powder and its preparation |
| 04/06/2005 | CN1602902A Medicine for treating angina and preparation technology thereof |
| 04/06/2005 | CN1602901A Usage of Huoxiang Zhengqi formulation in the preparation of functional stomach dyskinesis treating medicine |
| 04/06/2005 | CN1602897A Prostatitis treating plaster |
| 04/06/2005 | CN1602896A Traditional Chinese medicine for treating aplastic anemia and its preparation process |
| 04/06/2005 | CN1602889A Preparation method of clindamycin phosphate powder injection |
| 04/06/2005 | CN1602888A Azithromycin enteric casing preparation and its preparing process |
| 04/06/2005 | CN1602887A Erythromycin ethylsuccinate for injection and its preparation process and application |
| 04/06/2005 | CN1602886A Pharmaceutical compositions and its application |
| 04/06/2005 | CN1602885A Meridian dredging capsule containing panax pseudo-ginseng tri-alcohol saponin and its preparation process |
| 04/06/2005 | CN1602884A Blood vessel dredging capsule containing panax pseudo-ginseng tri-alclhol saponin and its preparation process |
| 04/06/2005 | CN1602883A Pharmaceutical compositions containing ginsenoside, safflor yellow and its preparation and application |
| 04/06/2005 | CN1602882A Orally disintegrating tablet of gypenosides and its preparation process |
| 04/06/2005 | CN1602881A Diabetin for injection and its preparation process |